This biomolecular network has provided a richer setting to characterize genes found to be involved in AD and to identify AMP-activated protein kinase (AMPK) signaling, a metabolic sensoring pathway and energy regulators including neuropeptides, as a major player in the pathophysiology of AD, which could explain various aspects of AD pathogenesis. This evidence concerns the gene PRKAA2 and Alzheimer disease.